The article is a review of domestic and foreign literature sources covering the development of complications and long-term prognoses during radical cystectomy, as well as the history of the development of the method. The gold standard for the treatment of muscle invasive bladder cancer (MIBC) is radical cystectomy with bilateral pelvic lymph node dissection. The high incidence of intra- and postoperative complications, as well as a large number of repeat visits (up to 25 %) in the first 30 days after open radical cystectomy necessitates a search and implementation of new methods of surgical treatment, one of which is robotic-assisted radical cystectomy (RARC). The robotic method reduces the need for intra- and postoperative blood transfusion, but does not significantly improve the patient’s quality of life compared to open surgery. The main disadvantage of the RARС is the long operation time. Urinary drainage is a necessary component of radical cystectomy. The most modern methods of derivation are «dry» stoma placement and orthotopic bladder surgery with urination along the native urethra. However, the choice of urinary drainage must be made based on a number of factors, including the patient’s comorbidities, surgical feasibility, postoperative care capacity, and patient preference.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.